An Evidence-Based Approach to the Management of Pancreatic Cancer

摘要: n 2001, a number of prominent pancreas cancer specialists from the medical community met with industry and pancreatic advocacy partners to make comprehensive formal recommendations for National Cancer Institute’s research agenda. They published an executive summary identifying barriers progress highlighted priorities that could lead real this cancer. As we approach end 2004, much has changed, yet remained same management We now have understanding how normal duct epithelium progresses infiltrating at molecular level. finally available reliable mouse models early ductal lesions3 will provide unprecedented potential identify lesions allow testing new drugs prevention treatment. The technology tumor animal xenografting exists more efficient mechanisms drug resistance.